Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

UK Outlook 2018: All To Play For In Technology Adoption With AAR Set For Take Off

Executive Summary

Navigating the UK medtech innovation landscape is a notoriously complicated exercise, so industry is hoping the recently released Accelerated Access Review will have positive outcomes as 2018 unfolds. Andrew Davies, market access director for the Association of British Healthcare Industries,  says a simplified system of market access for medtech would bring benefits across the board.

Advertisement

Related Content

UK Outlook 2018: Medtech Readies For Change To FOM System Of Value-Based Procurement
Revolutionary EU HTA Cooperation Proposal Will Use MDR/IVDR Platforms
UK Medtech To Leverage Accelerated Access Opportunity, Regardless Of The 'B' Word
UK NICE’s MedTech Scan Will Give NHS Early View Of Innovation
EU Medtechs Keep Open Mind On HTA Options In Wider Market Access Plan

Topics

Advertisement
UsernamePublicRestriction

Register

MT122181

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel